MustGrow Secures $2 Million Line of Credit with CIBC; Guaranteed by EDC
MWN-AI** Summary
MustGrow Biologics Corp. (TSXV: MGRO) has successfully secured a $2 million line of credit (LOC) with the Canadian Imperial Bank of Commerce (CIBC), with backing from Canada's Export Development Canada (EDC). This financial arrangement is set against an interest rate linked to the Canadian prime rate, currently at 4.95% plus 1.00% annually. The funding will primarily facilitate the production of MustGrow's organic mustard-derived biofertility product, TerraSanteTM, which has seen a surge in demand among U.S. commercial farmers.
President and CEO Corey Giasson emphasized the rising interest from large U.S. farming operations, affirming the product's effectiveness and economic viability. The LOC will also assist in meeting working capital needs for MustGrow's Canadian sales and distribution division, NexusBioAg. Giasson indicated plans to potentially expand the LOC to further bolster production capabilities in response to the increasing U.S. demand for TerraSanteTM.
MustGrow is positioned as a comprehensive provider of biological and regenerative agricultural solutions, promoting sustainable farming practices. The company's portfolio includes various eco-friendly alternatives to synthetic chemicals and fertilizers, alongside its proprietary biofertility and biocontrol products derived from mustard. MustGrow is actively expanding its operations beyond North America, collaborating with global agricultural companies like Bayer AG to commercialize its innovative technologies.
With around 58.9 million common shares issued, MustGrow is committed to enhancing shareholder value through its extensive intellectual property, which includes approximately 109 patents. The company’s focus on sustainable alternatives aligns with evolving agricultural trends, reinforcing its market presence in both domestic and international arenas. For more information, visit www.mustgrow.ca.
MWN-AI** Analysis
MustGrow Biologics Corp. (TSXV: MGRO), having secured a $2 million line of credit (LOC) guaranteed by Export Development Canada (EDC), presents an interesting investment opportunity that is poised for growth in the organic agricultural sector. With increasing demand for its biological product, TerraSante™, particularly among U.S. commercial farmers, MustGrow is strategically positioned to capitalize on market trends favoring sustainable agriculture.
Investors should note the benefits of the secured LOC, which features favorable terms due to EDC's backing. This funding will enhance MustGrow's capacity to expand inventory, directly supporting its operations in both the U.S. and Canadian markets. Given the current Canadian prime rate of 4.95%, the interest rate linked to the LOC (prime + 1.00%) remains competitive, making this financing attractive for scaling operations.
MustGrow’s strategy to leverage its patented technologies and product lines that serve as eco-friendly alternatives to synthetic chemicals reflects a robust response to regulatory pressures and consumer preferences for organic products. The company's ability to maintain a diverse portfolio, including partnerships with global players like Bayer AG, illustrates a broader market engagement that could mitigate risks associated with regional fluctuations in demand.
From a market analysis perspective, the growing adoption of biological products in agriculture aligns with broader sustainability trends, suggesting potential for increasing revenue streams. The company’s commitment to innovation in the face of rising agricultural challenges makes it an appealing prospect for investors who prioritize environmentally responsible investments.
In conclusion, MustGrow Biologics Corp. exhibits strong fundamentals and growth potential. Investors would do well to consider positioning in this company, especially as agricultural markets continue to shift toward sustainability, potentially driving substantial long-term returns. However, due diligence is recommended, given the inherent risks associated with agricultural sectors and reliance on regulatory developments.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Saskatoon, Saskatchewan--(Newsfile Corp. - September 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce it has secured a $2.0 million line of credit with Canadian Imperial Bank of Commerce, guaranteed by Canada's Export Development Canada ("EDC") (the "LOC").
Access to funds will allow MustGrow to produce its organic mustard-derived biofertility product TerraSanteTM to meet growing demand from U.S. commercial farming operations. In addition, the LOC will help support working capital requirements for its Canadian sales and distribution division, NexusBioAg.
The LOC carries an interest rate linked to Canada's prime rate plus 1.00%, per annum. The current Canadian prime rate is 4.95%. EDC has guaranteed the LOC on MustGrow's behalf. MustGrow will endeavour to increase the LOC size to support accelerating TerraSanteTM product demand in the U.S.
"We are seeing significant uptake from large U.S. commercial farming operations, which further validates the effectiveness, efficiency, and economics of our organic biofertility product TerraSanteTM," asserted Corey Giasson, President and CEO of MustGrow. "Utilizing our LOC on such favourable terms will enable us to build inventory to meet increasing U.S. demand for TerraSanteTM and support NexusBioAg's growing operations here in Canada."
About MustGrow
MustGrow Biologics Corp. is a fully-integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, MustGrow offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants and foliar products. These products are synergistically distributed alongside MustGrow's wholly-owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, MustGrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize MustGrow's wholly-owned proprietary products and technologies. The Company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio of approximately 109 patents that are currently issued and pending, and the sales and distribution of its proprietary and third-party product lines through NexusBioAg. MustGrow is a publicly traded company (TSXV: MGRO) and has approximately 58.9 million common shares issued and outstanding and 67.5 million shares fully diluted. For further details, please visit www.mustgrow.ca.
Contact Information
Corey Giasson Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
MustGrow Forward-Looking Statements
Certain statements included in this news release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow's actual results and financial condition to differ materially from those indicated in the forward-looking statements include: the receipt of final approval by the TSXV and those risks described in more detail in MustGrow's Annual Information Form for the year ended December 31, 2024 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.
© 2025 MustGrow Biologics Corp. All rights reserved.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265763
FAQ**
How might the recent funding from MustGrow Biologics Corp. influence the agricultural practices in Saskatoon and the surrounding regions, particularly concerning sustainable farming initiatives linked to "Mustgrow Biologics Corp. - Common Shares MGRO:CC"?
With the growing demand for TerraSanteTM products in the U.S., what potential impacts could this have on local employment and economic growth in Saskatoon as MustGrow Biologics Corp. expands its operations?
What are the implications of MustGrow Biologics Corp.'s partnership with Canadian Imperial Bank of Commerce and EDC for small agricultural businesses in Saskatoon seeking funding and support for sustainable agricultural solutions under "Mustgrow Biologics Corp. - Common Shares MGRO:CC"?
How does MustGrow Biologics Corp.'s focus on organic solutions align with the agricultural trends and sustainability goals in Saskatoon, and what opportunities might arise for local farmers from innovations in biofertility products like TerraSanteTM?
**MWN-AI FAQ is based on asking OpenAI questions about Mustgrow Biologics Corp. - Common Shares (CNQC: MGRO:CC).
NASDAQ: MGRO:CC
MGRO:CC Trading
-0.32% G/L:
$3.10 Last:
26,903 Volume:
$3.07 Open:
